Last reviewed · How we verify

NCT06277544

Analysis of Prognosis and Risk Factors of LAL Reconstruction Procedure for Patients With AF of the LAL: a Prospective Cohort Study

Active, enrolled Last updated 26 February 2024
What this trial tests

trial testing lateral ankle ligament repair or reconstruction in Avulsion Fracture of Lateral Ankle Ligament in 120 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
27 January 2024
Primary endpoint
30 June 2026
30 June 2026

Quick facts

Lead sponsorPeking University Third Hospital
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment120
Start date27 January 2024
Primary completion30 June 2026
Estimated completion30 June 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking University Third Hospital

Who can join

Adults 18 to 60, any sex, with Avulsion Fracture of Lateral Ankle Ligament. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the clinical outcomes of CAI patients with and without lateral ankle avulsion fracture after ligament repair/reconstruction, and to analyze the risk factors associated with the outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Peking University Third Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06277544.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing